SCLXW icon

Scilex Holding Co Warrant

0.1200 USD
+0.0018
1.52%
At close Updated Apr 17, 4:00 PM EDT
1 day
1.52%
5 days
41.51%
1 month
-6.9%
3 months
-4.08%
6 months
-10.71%
Year to date
8.89%
1 year
139.04%
5 years
-74.2%
10 years
-79.38%
 

About: Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.

Employees: 34

0
Funds holding %
of 8,118 funds
Analysts bullish %
Positive news %
Price charts implemented using Lightweight Charts™